Annual Drug Patent Expirations for INJECTAFER
Injectafer is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
Drug patent litigation for INJECTAFER.
This drug has sixty-one patent family members in thirty-two countries.
The generic ingredient in INJECTAFER is ferric carboxymaltose. One supplier is listed for this compound. Additional details are available on the ferric carboxymaltose profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
